Used primarily in research settings as a selective dopamine reuptake inhibitor, this compound has been studied for its potential in understanding dopaminergic pathways in the central nervous system. It shows interest in neuroscience for modeling conditions related to dopamine dysregulation, such as attention deficit disorders and substance dependence. Due to its ability to enhance dopamine availability in synaptic clefts, it has served as a reference tool in studies assessing psychostimulant mechanisms. Its application remains limited to laboratory and preclinical research, with no approved therapeutic use in humans.